↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

161 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   1% lignocaine   Lidocaine   D00358, D02086, D08127   2件: SCN1A, SCN5A   2件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse   1件:
84 
 2   13nh3 pet/ct scan   -   -   -   -   1件:
84 
 3   18f fdg   Fludeoxyglucose F-18   -   -   -   1件:
84 
 4   18f-fdg   Fludeoxyglucose F-18   -   -   -   7件:
6,
13,
46,
53,
84,
127,
300 
 5   18f-fluorodeoxyglucose   -   -   -   -   1件:
84 
 6   18f-fspg   Florilglutamic acid F-18   -   -   -   1件:
84 
 7   18fdg pet/ct scan   -   -   -   -   1件:
84 
 8   2% lignocaine   Lidocaine   D00358, D02086, D08127   2件: SCN1A, SCN5A   2件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse   1件:
84 
 9   68ga-dotanoc   -   -   -   -   1件:
84 
 10   68ga-dotatate   Dotatate gallium Ga-68, Dotatate   -   -   -   1件:
84 
 11   68ga-dotatate pet/ct   Dotatate gallium Ga-68, Dotatate   -   -   -   1件:
84 
 12   99m technetium infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
84 
 13   99mtc-infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
84 
 14   Abatacept   Abatacept   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 15   Acthar gel   -   -   -   -   4件:
13,
46,
49,
84 
 16   Acthar gel (adrenocorticotropic hormone)   Corticotropin   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   1件:
84 
 17   Acthar gel 40 units twice weekly   -   -   -   -   1件:
84 
 18   Acthar gel 80 units twice weekly.   -   -   -   -   1件:
84 
 19   Acz885   -   -   -   -   5件:
46,
84,
106,
107,
108 
 20   Adalimumab   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271 
 21   Adrenocorticotropic hormone   Corticotropin   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   3件:
13,
50,
84 
 22   All subjects will receive maraviroc 300mg orally twice a day for 6 weeks   Maraviroc   D06670   1件: CCR5   4件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human immunodeficiency virus 1 infection   1件:
84 
 23   Allogeneic stem cell transplantation   -   -   -   -   2件:
49,
84 
 24   Ambrisentan   Ambrisentan   D07077   1件: EDNRA   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   6件:
51,
84,
85,
86,
88,
211 
 25   Anakinra   Anakinra   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   15件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
84,
86,
106,
107,
299 
 26   Analysis of gamma globulin   -   -   -   -   1件:
84 
 27   Antibiotic regimen   -   -   -   -   1件:
84 
 28   Antituberculous therapy along with steroids   -   -   -   -   1件:
84 
 29   Ara 290   -   -   -   -   1件:
84 
 30   Armodafinil   Armodafinil   D03215   1件: SLC6A3   1件: Dopaminergic synapse   3件:
6,
13,
84 
 31   Atorvastatin   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   1件: Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 32   Atyr1923 1.0 mg/kg   -   -   -   -   1件:
84 
 33   Atyr1923 3.0 mg/kg   -   -   -   -   1件:
84 
 34   Atyr1923 5.0 mg/kg   -   -   -   -   1件:
84 
 35   Autologous hematopoietic stem cell transplantation   -   -   -   -   1件:
84 
 36   Azithromycin   Azithromycin   D02134, D06390, D07486   -   -   6件:
13,
84,
85,
96,
228,
299 
 37   Azithromycin 250mg capsule   Azithromycin   D02134, D06390, D07486   -   -   1件:
84 
 38   Bardoxolone   Bardoxolone   D09584   -   -   7件:
66,
67,
84,
85,
86,
218,
222 
 39   Bardoxolone methyl   Bardoxolone, Bardoxolone methyl   D09584, D09585   -   -   7件:
66,
67,
84,
85,
86,
218,
222 
 40   Bosentan   Bosentan   D01227, D07538   2件: EDNRA, EDNRB   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   9件:
13,
41,
47,
51,
84,
85,
86,
88,
210 
 41   Bosentan monohydrate   Bosentan, bosentan monohydrate   D01227, D07538   2件: EDNRA, EDNRB   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   4件:
51,
84,
86,
88 
 42   C11-methionine   Methionine   D00019, D04983   -   -   1件:
84 
 43   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 44   Calcium citrate   Calcium   -   -   -   3件:
46,
84,
235 
 45   Calcium citrate with vitamin d2   Calcium, Ergocalciferol   D00187   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   1件:
84 
 46   Canakinumab   Canakinumab   D09315   1件: IL1B   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NOD-like receptor signaling pathway   9件:
46,
56,
84,
106,
107,
108,
113,
266,
269 
 47   Cc-100004   -   -   -   -   1件:
84 
 48   Cc-220   CC-220   -   -   -   2件:
49,
84 
 49   Cc-220 0.3 mg daily   CC-220   -   -   -   1件:
84 
 50   Cc-220 0.6mg daily   CC-220   -   -   -   1件:
84 
 51   Ciclesonide   Ciclesonide   D01703   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
84 
 52   Clarithromycin   Clarithromycin   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299 
 53   Cmk389   -   -   -   -   1件:
84 
 54   Cnto 148   -   -   -   -   3件:
46,
84,
271 
 55   Cnto1275   -   -   -   -   3件:
46,
84,
96 
 56   Corticosteroid   -   -   -   -   10件:
13,
42,
43,
44,
45,
66,
84,
96,
97,
222 
 57   Corticotropin   Corticotropin   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   7件:
2,
13,
46,
75,
78,
84,
222 
 58   Cu-64 dotatate   Dotatate   -   -   -   1件:
84 
 59   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 60   Cysteine   L-Cysteine   D00026, D02326   -   -   9件:
6,
13,
19,
84,
85,
88,
90,
254,
296 
 61   D-methylphenidate   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   2件: Dopaminergic synapse, Synaptic vesicle cycle   1件:
84 
 62   Dapsone   Dapsone   D00592   -   -   4件:
35,
42,
60,
84 
 63   Deltacortene*10cpr 25mg   -   -   -   -   1件:
84 
 64   Dexamethasone   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299 
 65   Dexamethasone 0,5mg   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
84 
 66   Dotanoc   -   -   -   -   1件:
84 
 67   Dotatate   Dotatate   -   -   -   3件:
41,
75,
84 
 68   Doxycycline   Doxycycline   D00307, D02129, D03903, D03904, D07876   -   -   15件:
13,
23,
28,
46,
84,
85,
89,
96,
97,
158,
162,
167,
227,
280,
299 
 69   Ergocalciferol   Ergocalciferol   D00187   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   5件:
46,
84,
96,
97,
299 
 70   Ethambutol   Ethambutol   D00878, D07925   -   -   2件:
84,
299 
 71   Fermented oyster extract   Oyster   -   -   -   1件:
84 
 72   Fluorine (18f) fludeoxyglucose   -   -   -   -   2件:
84,
85 
 73   Fluorodeoxyglucose   -   -   -   -   1件:
84 
 74   Folic acid   Folic acid   D00070   -   -   4件:
6,
46,
49,
84 
 75   Formalin   Formaldehyde   D00017   -   -   1件:
84 
 76   Ga-68-dota-noc   -   -   -   -   1件:
84 
 77   Gallium-68 dotatate   Dotatate   -   -   -   1件:
84 
 78   Gallium-68-dota-n-octreotide   Octreotide   D00442, D06495   1件: SSTR2   3件: Gastric acid secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
84 
 79   Glucocorticoid (prednisone or prednisolone)   Prednisolone, Ethanol   D00068, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02798, D03301, D04855, D06542   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
84 
 80   Golimumab   Golimumab   D04358   1件: TNF   9件: Adipocytokine signaling pathway, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   5件:
46,
84,
96,
97,
271 
 81   Golimumab liquid in prefilled syringe   Golimumab   D04358   1件: TNF   9件: Adipocytokine signaling pathway, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
46,
84 
 82   H.p. acthar gel   -   -   -   -   5件:
46,
49,
50,
84,
222 
 83   Habitrol   -   -   -   -   1件:
84 
 84   Heparin   Heparin   D07510   1件: SERPINC1   1件: Complement and coagulation cascades   11件:
60,
70,
79,
84,
107,
224,
226,
280,
299,
316,
317 
 85   Human anti tnf-alpha monoclonal antibody   -   -   -   -   2件:
46,
84 
 86   Human anti-il 12/23 monoclonal antibody   -   -   -   -   1件:
84 
 87   Humira   Isopropyl alcohol   D00137   -   -   6件:
46,
84,
96,
97,
269,
271 
 88   Hydroxychloroquine   Hydroxychloroquine   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299 
 89   Hydroxychloroquine + prednisone   Hydroxychloroquine, Ethanol   D00068, D02798, D04855, D06542, D08050   -   -   1件:
84 
 90   Ilaris   Canakinumab   D09315   1件: IL1B   3件: Cytokine-cytokine receptor interaction, MAPK signaling pathway, NOD-like receptor signaling pathway   6件:
56,
84,
106,
107,
108,
266 
 91   Iloprost   Iloprost   D02721   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   4件:
51,
84,
85,
86 
 92   Indium   Indium   -   -   -   3件:
28,
84,
299 
 93   Indium-111 pentreotide   Indium   -   -   -   1件:
84 
 94   Infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 95   Influenza vaccine   -   -   -   -   4件:
11,
13,
46,
84 
 96   Inhaled treprostinil   Treprostinil   D06213   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   2件:
84,
86 
 97   L-methionine   Methionine   D00019, D04983   -   -   1件:
84 
 98   L-methionine ([11c]methyl)   Methionine   D00019, D04983   -   -   1件:
84 
 99   Levaquin   Levofloxacin   D00588, D08120   -   -   1件:
84 
 100   Levofloxacin   Levofloxacin   D00588, D08120   -   -   2件:
84,
299 
 101   Lignocaine   Lidocaine   D00358, D02086, D08127   2件: SCN1A, SCN5A   2件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse   1件:
84 
 102   Low dose prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
84 
 103   Maraviroc   Maraviroc   D06670   1件: CCR5   4件: Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human immunodeficiency virus 1 infection   2件:
46,
84 
 104   Medium dose prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
84 
 105   Methionine   Methionine   D00019, D04983   -   -   6件:
34,
75,
84,
93,
229,
300 
 106   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 107   Methylphenidate   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   2件: Dopaminergic synapse, Synaptic vesicle cycle   7件:
6,
13,
34,
84,
113,
179,
206 
 108   Methylphenidate (overencapsulated)   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   2件: Dopaminergic synapse, Synaptic vesicle cycle   1件:
84 
 109   Methylphenidate 10mg tablets   Methylphenidate   D01296, D04999   2件: SLC6A2, SLC6A3   2件: Dopaminergic synapse, Synaptic vesicle cycle   1件:
84 
 110   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 111   Methylprednisolone bolus iv 15 mg/kg/d for 3 days.   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
84 
 112   Mibg   Iobenguane   D04559   -   -   1件:
84 
 113   Minomycin   Minocycline   D00850, D05045   -   -   1件:
84 
 114   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 115   N-acetyl-cysteine   L-Cysteine   D00026, D02326   -   -   1件:
84 
 116   Nicotine   Nicotine   D03365, D05156, D05157   16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   2件:
6,
84 
 117   Nicotine patch   Nicotine   D03365, D05156, D05157   16件: CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG   3件: Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction   2件:
6,
84 
 118   None   -   -   -   -   8件:
46,
78,
84,
96,
160,
161,
171,
299 
 119   Octreotide   Octreotide   D00442, D06495   1件: SSTR2   3件: Gastric acid secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   7件:
67,
75,
84,
85,
89,
193,
227 
 120   Octreotide lar / sandostatin lar (lar=long acting release)   Octreotide   D00442, D06495   1件: SSTR2   3件: Gastric acid secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
84 
 121   Orencia   Abatacept   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   9件:
46,
50,
51,
53,
65,
84,
96,
97,
271 
 122   Oxygen   Oxygen   D00003   -   -   14件:
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
226,
299,
330 
 123   Oyster   Oyster   -   -   -   1件:
84 
 124   Pd 0360324   -   -   -   -   2件:
46,
84 
 125   Pda001 (cenplacel-l)   -   -   -   -   1件:
84 
 126   Pentoxifylline   Pentoxifylline   D00501   -   -   10件:
26,
56,
84,
93,
96,
113,
220,
222,
296,
298 
 127   Pirfenidone   Pirfenidone   D01583   6件: CCL2, IL10, IL1A, IL1B, IL6, TNF   5件: Cellular senescence, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, TGF-beta signaling pathway, TNF signaling pathway   10件:
34,
46,
50,
51,
58,
84,
85,
164,
222,
228 
 128   Plaquenil*25cpr riv 200mg   Hydroxychloroquine   D08050   -   -   1件:
84 
 129   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 130   Prednisone   Ethanol   D00068, D02798, D04855, D06542   -   -   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 131   Propofol   Propofol   D00549   16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   2件: GABAergic synapse, Neuroactive ligand-receptor interaction   8件:
6,
21,
22,
34,
46,
84,
98,
296 
 132   Quercetin   Quercetin   -   -   -   5件:
84,
85,
192,
285,
299 
 133   Remicade   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   8件:
46,
49,
56,
84,
85,
96,
97,
271 
 134   Repository corticotropin injection   Corticotropin   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   5件:
2,
13,
46,
84,
222 
 135   Repository corticotropin injection -treatment extension   Corticotropin   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   1件:
84 
 136   Rifampin   Rifampicin   D00211   -   -   5件:
6,
13,
84,
86,
299 
 137   Riociguat   Riociguat   D09572   3件: GUCY1A1, GUCY1A2, GUCY1B1   2件: Platelet activation, Vascular smooth muscle contraction   6件:
51,
84,
86,
88,
225,
299 
 138   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 139   Roflumilast   Roflumilast   D05744   4件: PDE4A, PDE4B, PDE4C, PDE4D   1件: cAMP signaling pathway   2件:
84,
299 
 140   Rubidium   Rubidium   -   -   -   1件:
84 
 141   Same   Ademetionine   D07128   -   -   15件:
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172 
 142   Sandostatin lar   Octreotide   D00442, D06495   1件: SSTR2   3件: Gastric acid secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   4件:
67,
84,
193,
227 
 143   Sarilumab   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   4件:
41,
46,
84,
107 
 144   Sarilumab 200 mg/1.14 ml subcutaneous solution [kevzara]_#1   Sarilumab   D10161   1件: IL6R   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   1件:
84 
 145   Schisandra chinensis extract   -   -   -   -   1件:
84 
 146   Seasonal influenza vaccine available for the 2012-2013 vaccine campaign   -   -   -   -   1件:
84 
 147   Selexipag   Selexipag   D09994   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   5件:
51,
70,
84,
86,
88 
 148   Tadalafil   Tadalafil   D02008   1件: PDE5A   1件: Purine metabolism   6件:
6,
51,
75,
84,
86,
113 
 149   Thalidomide   Thalidomide   D00754   1件: TNF   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, TNF signaling pathway   18件:
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331 
 150   Tofacitinib   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   9件:
46,
49,
50,
51,
84,
96,
97,
107,
271 
 151   Tofacitinib 5 mg twice daily   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   1件:
84 
 152   Tofacitinib 5mg [xeljanz] 1 year open-label extension   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   1件:
84 
 153   Tofacitinib 5mg oral tablet [xeljanz] 16 week trial   Tofacitinib   D09970   4件: JAK1, JAK2, JAK3, TYK2   2件: Chemokine signaling pathway, JAK-STAT signaling pathway   1件:
84 
 154   Tracleer   Bosentan   D01227, D07538   2件: EDNRA, EDNRB   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   8件:
13,
51,
84,
85,
86,
88,
210,
211 
 155   Tranilast   Tranilast   D02027   -   -   4件:
46,
84,
106,
113 
 156   Treprostinil   Treprostinil   D06213   1件: PTGIR   3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction   5件:
51,
84,
85,
86,
88 
 157   Ursodeoxycholic acid   Ursodeoxycholic acid   D00734   1件: NR1H4   1件: Bile secretion   8件:
6,
67,
84,
93,
94,
95,
96,
97 
 158   Ustekinumab   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   15件:
37,
41,
46,
49,
50,
53,
56,
65,
84,
93,
96,
97,
162,
269,
271 
 159   Ustekinumab liquid in prefilled syringe   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   1件:
84 
 160   Vitamin d2   Ergocalciferol   D00187   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   2件:
84,
299 
 161   Water   Water   D00001   -   -   18件:
2,
5,
6,
13,
17,
19,
35,
46,
53,
57,
63,
65,
67,
84,
97,
226,
278,
299 

先頭へ